The company plans to invest GBP 30 million over the next five years
Brinton Pharmaceutical has decided to invest in a global research and development centre in the UK. The company plans to invest GBP 30 million over the next five years to strengthen its product pipelines, create 300 highly skilled jobs and develop innovative products for its global consumers.
Brinton is committed to developing innovative formulations for consumer healthcare as well as speciality care in dermatology, paediatric, respiratory and family physician specialities as well as nutraceuticals. The organisation has introduced 14 unique formulations in India to address the unmet patient needs of people in the country. The company is planning to use its global research and development centre in the UK to create affordable novel products using niche technologies.
The team understands the critical importance of the highly skilled sector human capital available in the UK which can help them in developing an innovative portfolio of products for the global life sciences market. Brinton Pharmaceuticals has ambitious growth plans for the UK and wants to be a key partner in the UK healthcare ecosystem to synthesise world-class research and innovation interventions leading to the making of top medical products. The company will also be creating high-value job opportunities across the various domains and skillsets of the life sciences industry in the UK.
